Evaluation of CK-MB isoform analysis for early diagnosis of myocardial infarction

Journal of Emergency Medicine

Volumn 17, Issue 1, 1999, Pages 75-79

  Bock, Jay L ^a,b   Brogan Jr , Gerard X ^a   McCuskey, Charles F ^a   Thode Jr , Henry C ^a   Hollander, Judd E ^a   Gunther, Tamara ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiac markers; CK MB; CK MB isoforms; Myocardial infarction

Indexed keywords

CREATINE KINASE MB;

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; AGED; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELIABILITY; REVIEW;

EID: 0032940690     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(98)00126-7     Document Type: Article

References (25)

1. Sarko J, Pollack CV. Beyond the twelve-lead electrocardiogram: diagnostic tests in the evaluation for suspected acute myocardial infarction in the emergency department, part II. J Emerg Med 1998;16:67-78.
2. Keffer JH. The cardiac profile and proposed practice guideline for acute ischemic heart disease. Am J Clin Pathol 1997;107:398-409.
3. Keffer JH. Myocardial markers of injury. Evolution and insights. Am J Clin Pathol 1996;105:305-20.
4. Mair J. Progress in myocardial damage detection: new biochemical markers for clinicians. Crit Rev Clin Lab Sci 1997;34:1-66.
5. Lee TH, Weisberg MC, Cook EF, Daley K, Brand DA, Goldman L. Evaluation of creatine kinase and creatine kinase-MB for diagnosing myocardial infarction: clinical impact in the emergency room. Arch Intern Med 1987;147:115-21.
6. Karcz A, Holbrook J, Burke MC, et al. Massachusetts emergency medicine closed malpractice claims: 1988-1990. Ann Emerg Med 1993;22:553-9.
7. Perryman MB, Knell JD, Roberts R. Carboxypeptidase-catalyzed hydrolysis of C-terminal lysine: mechanism for in vivo production of multiple forms of creatine kinase in plasma. Clin Chem 1984;30:662-4.
8. Puleo PR, Meyer D, Wathen C, et al. Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994;331:561-6.
9. Swaanenburg JC, Pentinga M, DeJongste MJ, Kema IP, Weening MH. Implications of automated creatine kinase (CK)-MM1,2,3/CK-MB1,2 isoform analysis as an early marker for the detection of myocardial tissue damage. Scand J Clin Lab Invest 1996;56:627-33.
10. Secchiero S, Altinier S, Zaninotto M, Lachin M, Plebani M. Evaluation of a new automated system for the determination of CK-MB isoforms. J Clin Lab Anal 1995;9:359-65.
11. McBride JH, Schotters SB. Immunochemical extraction and automated measurement of plasma creatine kinase MB isoenzyme and creatine kinase MB2 isoform. J Clin Lab Anal 1997;11:163-8.
12. Bhayana V, Cohoe S, Leung FY, Jablonsky G, Henderson AR. Diagnostic evaluation of creatine kinase-2 mass and creatine kinase-3 and -2 isoform ratios in early diagnosis of acute myocardial infarction. Clin Chem 1993;39:488-95.
13. Mair J, Morandell D, Genser N, Lechleitner P, Dienstl F, Puschendorf B. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. Clin Chem 1995;41:1266-72.
14. Heiland O, Dickstein K. Cardiac markers in the early hours of acute myocardial infarction: clinical performance of creatine kinase, creatine kinase MB isoenzyme (activity and mass concentration), creatine kinase MM and MB subform ratios, myoglobin and cardiac troponin T. Scand J Clin Lab Invest 1996;56:701-13.
15. Mair J, Artner-Dworzak E, Dienstl A, et al. Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB. Am J Cardiol 1991;68:1545-50.
16. Collinson PO, Rosalki SB, Kuwana T, et al. Early diagnosis of acute myocardial infarction by CK-MB mass measurements. Ann Clin Biochem 1992;29:43-7.
17. Bakker AJ, Koelemay MJW, Gorgels JPMC, et al. Failure of new biochemical markers to exclude acute myocardial infarction at admission. Lancet 1993;342:1220-2.
18. Marin MM, Teichman SL. Use of rapid serial sampling of creatine kinase MB for very early detection of myocardial infarction in patients with acute chest pain. Am Heart J 1992;123:354-61.
19. Brogan GX, Jr., Friedman S, McCuskey C, et al. Evaluation of a new rapid quantitative immunoassay for serum myoglobin versus CK-MB for ruling out acute myocardial infarction in the emergency department. Ann Emerg Med 1994;24:665-71.
20. Mair J, Smidt J, Artner-Dworzak E, Lechleitner P, Dienstl F, Puschendorf B. Rapid diagnosis of myocardial infarction by immunoturbidimetric myoglobin measurement. Lancet 1991;337:1343-4.
21. Mair J, Artner-Dworzak E, Lechleitner P, et al. Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin. Br Heart J 1992;68:462-8.
22. Tucker JF, Collins RA, Anderson AJ, et al. Value of serial myoglobin levels in the early diagnosis of patients admitted for acute myocardial infarction. Ann Emerg Med. 1994;24:704-8.
23. Kilpatrick WS, Wosornu D, McGuinness JB, Glen ACA. Early diagnosis of acute myocardial infarction: CK-MB and myoglobin compared. Ann Clin Biochem 1993;30:435-8.
24. Davis CP, Barrett K, Torre P, Wacasey K. Serial myoglobin levels for patients with possible myocardial infarction. Acad Emerg Med 1996;3:590-7.
25. Keffer JH. Subforms of creatine kinase MB in the diagnosis of myocardial infarction [letter]. N Engl J Med 1995;332:608.